Abstract
Summary
The global market for Compound Glycyrrhizin was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Compound Glycyrrhizin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Compound Glycyrrhizin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Compound Glycyrrhizin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Compound Glycyrrhizin include Xi'an Lijun Pharmaceutical Co., Ltd., Akiyama Tablet Co., Ltd. (Japan), Eisai (China) Pharmaceutical Co., Ltd., Lepu Pharmaceutical Co., Ltd., Beijing Kaiin Technology Co., Ltd., Origin of Mino, Shandong Ruiyang, Chengdu Yuandong Bio and Weifang Zhongshi, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Compound Glycyrrhizin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Compound Glycyrrhizin by region & country, by Type, and by Application.
The Compound Glycyrrhizin market size, estimations, and forecasts are provided in terms of sales volume (KG) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compound Glycyrrhizin.
Market Segmentation
By Company
Xi'an Lijun Pharmaceutical Co., Ltd.
Akiyama Tablet Co., Ltd. (Japan)
Eisai (China) Pharmaceutical Co., Ltd.
Lepu Pharmaceutical Co., Ltd.
Beijing Kaiin Technology Co., Ltd.
Origin of Mino
Shandong Ruiyang
Chengdu Yuandong Bio
Weifang Zhongshi
Fujian Lijiexun
CSPC Ouyi
Segment by Type:
PVC Sheet Packing
Aluminum Foil Packing
Segment by Application
Chronic Liver Disease
Eczema
Dermatitis
Alopecia Areata
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Compound Glycyrrhizin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Compound Glycyrrhizin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Compound Glycyrrhizin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
North American market for Compound Glycyrrhizin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Compound Glycyrrhizin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Compound Glycyrrhizin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Compound Glycyrrhizin include Xi'an Lijun Pharmaceutical Co., Ltd., Akiyama Tablet Co., Ltd. (Japan), Eisai (China) Pharmaceutical Co., Ltd., Lepu Pharmaceutical Co., Ltd., Beijing Kaiin Technology Co., Ltd., Origin of Mino, Shandong Ruiyang, Chengdu Yuandong Bio and Weifang Zhongshi, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Compound Glycyrrhizin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Compound Glycyrrhizin by region & country, by Type, and by Application.
The Compound Glycyrrhizin market size, estimations, and forecasts are provided in terms of sales volume (KG) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compound Glycyrrhizin.
Market Segmentation
By Company
Xi'an Lijun Pharmaceutical Co., Ltd.
Akiyama Tablet Co., Ltd. (Japan)
Eisai (China) Pharmaceutical Co., Ltd.
Lepu Pharmaceutical Co., Ltd.
Beijing Kaiin Technology Co., Ltd.
Origin of Mino
Shandong Ruiyang
Chengdu Yuandong Bio
Weifang Zhongshi
Fujian Lijiexun
CSPC Ouyi
Segment by Type:
PVC Sheet Packing
Aluminum Foil Packing
Segment by Application
Chronic Liver Disease
Eczema
Dermatitis
Alopecia Areata
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Compound Glycyrrhizin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Compound Glycyrrhizin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Compound Glycyrrhizin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Compound Glycyrrhizin Product Introduction
1.2 Global Compound Glycyrrhizin Market Size Forecast
1.2.1 Global Compound Glycyrrhizin Sales Value (2019-2030)
1.2.2 Global Compound Glycyrrhizin Sales Volume (2019-2030)
1.2.3 Global Compound Glycyrrhizin Sales Price (2019-2030)
1.3 Compound Glycyrrhizin Market Trends & Drivers
1.3.1 Compound Glycyrrhizin Industry Trends
1.3.2 Compound Glycyrrhizin Market Drivers & Opportunity
1.3.3 Compound Glycyrrhizin Market Challenges
1.3.4 Compound Glycyrrhizin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Compound Glycyrrhizin Players Revenue Ranking (2023)
2.2 Global Compound Glycyrrhizin Revenue by Company (2019-2024)
2.3 Global Compound Glycyrrhizin Players Sales Volume Ranking (2023)
2.4 Global Compound Glycyrrhizin Sales Volume by Company Players (2019-2024)
2.5 Global Compound Glycyrrhizin Average Price by Company (2019-2024)
2.6 Key Manufacturers Compound Glycyrrhizin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Compound Glycyrrhizin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Compound Glycyrrhizin
2.9 Compound Glycyrrhizin Market Competitive Analysis
2.9.1 Compound Glycyrrhizin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Compound Glycyrrhizin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compound Glycyrrhizin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PVC Sheet Packing
3.1.2 Aluminum Foil Packing
3.2 Global Compound Glycyrrhizin Sales Value by Type
3.2.1 Global Compound Glycyrrhizin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Compound Glycyrrhizin Sales Value, by Type (2019-2030)
3.2.3 Global Compound Glycyrrhizin Sales Value, by Type (%) (2019-2030)
3.3 Global Compound Glycyrrhizin Sales Volume by Type
3.3.1 Global Compound Glycyrrhizin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Compound Glycyrrhizin Sales Volume, by Type (2019-2030)
3.3.3 Global Compound Glycyrrhizin Sales Volume, by Type (%) (2019-2030)
3.4 Global Compound Glycyrrhizin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Chronic Liver Disease
4.1.2 Eczema
4.1.3 Dermatitis
4.1.4 Alopecia Areata
4.1.5 Other
4.2 Global Compound Glycyrrhizin Sales Value by Application
4.2.1 Global Compound Glycyrrhizin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Compound Glycyrrhizin Sales Value, by Application (2019-2030)
4.2.3 Global Compound Glycyrrhizin Sales Value, by Application (%) (2019-2030)
4.3 Global Compound Glycyrrhizin Sales Volume by Application
4.3.1 Global Compound Glycyrrhizin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Compound Glycyrrhizin Sales Volume, by Application (2019-2030)
4.3.3 Global Compound Glycyrrhizin Sales Volume, by Application (%) (2019-2030)
4.4 Global Compound Glycyrrhizin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Compound Glycyrrhizin Sales Value by Region
5.1.1 Global Compound Glycyrrhizin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Compound Glycyrrhizin Sales Value by Region (2019-2024)
5.1.3 Global Compound Glycyrrhizin Sales Value by Region (2025-2030)
5.1.4 Global Compound Glycyrrhizin Sales Value by Region (%), (2019-2030)
5.2 Global Compound Glycyrrhizin Sales Volume by Region
5.2.1 Global Compound Glycyrrhizin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Compound Glycyrrhizin Sales Volume by Region (2019-2024)
5.2.3 Global Compound Glycyrrhizin Sales Volume by Region (2025-2030)
5.2.4 Global Compound Glycyrrhizin Sales Volume by Region (%), (2019-2030)
5.3 Global Compound Glycyrrhizin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Compound Glycyrrhizin Sales Value, 2019-2030
5.4.2 North America Compound Glycyrrhizin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Compound Glycyrrhizin Sales Value, 2019-2030
5.5.2 Europe Compound Glycyrrhizin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Compound Glycyrrhizin Sales Value, 2019-2030
5.6.2 Asia Pacific Compound Glycyrrhizin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Compound Glycyrrhizin Sales Value, 2019-2030
5.7.2 South America Compound Glycyrrhizin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Compound Glycyrrhizin Sales Value, 2019-2030
5.8.2 Middle East & Africa Compound Glycyrrhizin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Compound Glycyrrhizin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Compound Glycyrrhizin Sales Value
6.2.1 Key Countries/Regions Compound Glycyrrhizin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Compound Glycyrrhizin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Compound Glycyrrhizin Sales Value, 2019-2030
6.3.2 United States Compound Glycyrrhizin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Compound Glycyrrhizin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Compound Glycyrrhizin Sales Value, 2019-2030
6.4.2 Europe Compound Glycyrrhizin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Compound Glycyrrhizin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Compound Glycyrrhizin Sales Value, 2019-2030
6.5.2 China Compound Glycyrrhizin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Compound Glycyrrhizin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Compound Glycyrrhizin Sales Value, 2019-2030
6.6.2 Japan Compound Glycyrrhizin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Compound Glycyrrhizin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Compound Glycyrrhizin Sales Value, 2019-2030
6.7.2 South Korea Compound Glycyrrhizin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Compound Glycyrrhizin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Compound Glycyrrhizin Sales Value, 2019-2030
6.8.2 Southeast Asia Compound Glycyrrhizin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Compound Glycyrrhizin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Compound Glycyrrhizin Sales Value, 2019-2030
6.9.2 India Compound Glycyrrhizin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Compound Glycyrrhizin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Xi'an Lijun Pharmaceutical Co., Ltd.
7.1.1 Xi'an Lijun Pharmaceutical Co., Ltd. Company Information
7.1.2 Xi'an Lijun Pharmaceutical Co., Ltd. Introduction and Business Overview
7.1.3 Xi'an Lijun Pharmaceutical Co., Ltd. Compound Glycyrrhizin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Xi'an Lijun Pharmaceutical Co., Ltd. Compound Glycyrrhizin Product Offerings
7.1.5 Xi'an Lijun Pharmaceutical Co., Ltd. Recent Development
7.2 Akiyama Tablet Co., Ltd. (Japan)
7.2.1 Akiyama Tablet Co., Ltd. (Japan) Company Information
7.2.2 Akiyama Tablet Co., Ltd. (Japan) Introduction and Business Overview
7.2.3 Akiyama Tablet Co., Ltd. (Japan) Compound Glycyrrhizin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Akiyama Tablet Co., Ltd. (Japan) Compound Glycyrrhizin Product Offerings
7.2.5 Akiyama Tablet Co., Ltd. (Japan) Recent Development
7.3 Eisai (China) Pharmaceutical Co., Ltd.
7.3.1 Eisai (China) Pharmaceutical Co., Ltd. Company Information
7.3.2 Eisai (China) Pharmaceutical Co., Ltd. Introduction and Business Overview
7.3.3 Eisai (China) Pharmaceutical Co., Ltd. Compound Glycyrrhizin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Eisai (China) Pharmaceutical Co., Ltd. Compound Glycyrrhizin Product Offerings
7.3.5 Eisai (China) Pharmaceutical Co., Ltd. Recent Development
7.4 Lepu Pharmaceutical Co., Ltd.
7.4.1 Lepu Pharmaceutical Co., Ltd. Company Information
7.4.2 Lepu Pharmaceutical Co., Ltd. Introduction and Business Overview
7.4.3 Lepu Pharmaceutical Co., Ltd. Compound Glycyrrhizin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Lepu Pharmaceutical Co., Ltd. Compound Glycyrrhizin Product Offerings
7.4.5 Lepu Pharmaceutical Co., Ltd. Recent Development
7.5 Beijing Kaiin Technology Co., Ltd.
7.5.1 Beijing Kaiin Technology Co., Ltd. Company Information
7.5.2 Beijing Kaiin Technology Co., Ltd. Introduction and Business Overview
7.5.3 Beijing Kaiin Technology Co., Ltd. Compound Glycyrrhizin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Beijing Kaiin Technology Co., Ltd. Compound Glycyrrhizin Product Offerings
7.5.5 Beijing Kaiin Technology Co., Ltd. Recent Development
7.6 Origin of Mino
7.6.1 Origin of Mino Company Information
7.6.2 Origin of Mino Introduction and Business Overview
7.6.3 Origin of Mino Compound Glycyrrhizin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Origin of Mino Compound Glycyrrhizin Product Offerings
7.6.5 Origin of Mino Recent Development
7.7 Shandong Ruiyang
7.7.1 Shandong Ruiyang Company Information
7.7.2 Shandong Ruiyang Introduction and Business Overview
7.7.3 Shandong Ruiyang Compound Glycyrrhizin Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Shandong Ruiyang Compound Glycyrrhizin Product Offerings
7.7.5 Shandong Ruiyang Recent Development
7.8 Chengdu Yuandong Bio
7.8.1 Chengdu Yuandong Bio Company Information
7.8.2 Chengdu Yuandong Bio Introduction and Business Overview
7.8.3 Chengdu Yuandong Bio Compound Glycyrrhizin Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Chengdu Yuandong Bio Compound Glycyrrhizin Product Offerings
7.8.5 Chengdu Yuandong Bio Recent Development
7.9 Weifang Zhongshi
7.9.1 Weifang Zhongshi Company Information
7.9.2 Weifang Zhongshi Introduction and Business Overview
7.9.3 Weifang Zhongshi Compound Glycyrrhizin Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Weifang Zhongshi Compound Glycyrrhizin Product Offerings
7.9.5 Weifang Zhongshi Recent Development
7.10 Fujian Lijiexun
7.10.1 Fujian Lijiexun Company Information
7.10.2 Fujian Lijiexun Introduction and Business Overview
7.10.3 Fujian Lijiexun Compound Glycyrrhizin Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Fujian Lijiexun Compound Glycyrrhizin Product Offerings
7.10.5 Fujian Lijiexun Recent Development
7.11 CSPC Ouyi
7.11.1 CSPC Ouyi Company Information
7.11.2 CSPC Ouyi Introduction and Business Overview
7.11.3 CSPC Ouyi Compound Glycyrrhizin Sales, Revenue and Gross Margin (2019-2024)
7.11.4 CSPC Ouyi Compound Glycyrrhizin Product Offerings
7.11.5 CSPC Ouyi Recent Development
8 Industry Chain Analysis
8.1 Compound Glycyrrhizin Industrial Chain
8.2 Compound Glycyrrhizin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Compound Glycyrrhizin Sales Model
8.5.2 Sales Channel
8.5.3 Compound Glycyrrhizin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer